This alphabetical keyword index is not exhaustive.

Effectiveness and efficiency of the search   B-III, 1.2

Election of states   C-II, 6

Electronic version of document cited   B-X, 11.2

Enabling disclosure of a prior document   G-VI, 4

Enabling disclosures   G-IV, 2

End of search   B-IV, 2.6

EPO as competent IPEA   C-II, 2

Errors in prior-art documents   G-IV, 8

Essential features   F-IV, 4.5

Annex Examples concerning essential features   F‑IV, An.

Cases where method steps require specific data processing means and/or require additional technical devices as essential features   F‑IV, 3.8.2

Definition of essential features   F‑IV, 4.5.2

Generalisation of essential features   F‑IV, 4.5.3

Implicit features   F‑IV, 4.5.4

Objections arising from missing essential features   F‑IV, 4.5.1

Ex post facto analysis   G-VII, 8


Examination of formal requirements   A‑VI

Claim to priority   A‑VI, 1

Examination of novelty   G‑VI, 7

Second non-medical use   G‑VI, 7.2

Second or further medical use of known pharmaceutical products   G‑VI, 7.1

Examination of observations by third parties   C‑VII, 3

Examination of the WO‑ISA and replies   C‑IV

Consequences of a restriction of the search   C‑IV, 4

Despatch of a further written opinion (Form 408)   C‑IV, 2

General procedure   C‑IV, 1

Late-filed reply after a first or further WO-IPEA (408) has been sent   C‑IV, 3

Top-up searches in PCT Chapter II   C‑IV, 5

Examination on filing   A‑II, 4

Defects   A‑II, 4.2

Filing of international applications and examination on filing   A‑II

Minimum requirements for according an international filing date   A‑II, 4.1

Examination practice   G‑II, 2

Examiner   B-I, 2

Consultation with other examiners   B‑I, 2.1

Examiner's approach   F‑V, 8

Determination of the invention first mentioned in the claims   F‑V, 8.2

Reasoning for a lack of unity objection   F‑V, 8.1

Examiner's dossier   B‑XI, 3.1

Review by the examiner   H‑II,

Search Division consisting of more than one examiner   B‑I, 2.2

Work of an examiner   C‑I, 2

Examining the validity of a right to priority   F-VI, 2.1

Example of the accessibility of objects used   G-IV, 6.2.4

Example of the inaccessibility of a process   G-IV, 6.2.5

Examples of applying the steps listed in GL/EPO G-VII, 5.4   G-VII, 5.4.2

Examples of impossibility to perform a meaningful search over the whole of the claimed scope   B-VIII, 3.1

Examples of quotation for non-patent literature   F-II,

Examples of quotation for patent literature   F-II,

Examples of refunds   A-III, 9.2.1

Examples of refunds no refund   A‑III,

Full refund   A‑III,

Partial refund   A‑III,

Exceptions   G-II, 5.3

Exceptions to patentability   G‑II, 4

Matter contrary to public order or morality   G‑II, 4.1

Surgery, therapy and diagnostic methods   G‑II, 4.2

Exclusions and exceptions for biotechnological inventions   G‑II, 5

Exclusions and exceptions for biotechnological inventions   G-II, 5

Biotechnological inventions   G‑II, 5.2

Exceptions   G‑II, 5.3

Microbiological processes   G‑II, 5.5

Plant and animal varieties, essentially biological processes for the production of plants or animals   G‑II, 5.4

Execution of drawings   A-V, 7

Cross-sections   A‑V, 7.3

Drawings of lines and strokes   A‑V, 7.1

Numbers, letters and reference signs   A‑V, 7.5

Scale of drawings   A‑V, 7.4

Shading   A‑V, 7.2

Variations in proportions   A‑V, 7.6

Exemptions from top-up search   C-IV, 5.2

Explanations under Rule 45bis.7(e)   B-XII, 7

Expression "in"   F-IV, 4.15

Expressions, etc., not to be used   F-II, 7

Categories   F‑II, 7.1

Disparaging statements   F‑II, 7.3

Expressions or drawings contrary to morality or public order   F‑II, 7.2

Irrelevant matter   F‑II, 7.4

Omission of matter from publication   F‑II, 7.5

Extension of the search   B-VI, 5.3

Extension of the time limit   C-VI, 3

Extent of generalisation   F-IV, 6.2

Quick Navigation